Brief: Ryvu Therapeutics Sets J Series Share Price For BioNTech At 48.86 Zlotys/SHR
Dec 15 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SETS FINAL PRICE OF J SERIES SHARES AT 55 ZLOTYS PER SHARE
* SETS ISSUE PRICE OF J SERIES SHARES IN TRANCHE FOR
BIONTECH AT
48.86 ZLOTYS PER SHARE
* 55 ZLOTYS PER SHARE PRICE SET FOR INDIVIDUAL AND
INSTITUTIONAL
INVESTORS
Source text for Eikon: ID:nEM9QyyQBa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project